In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after ...

Baxter International’s longtime CEO and board chair, José Almeida, is stepping down and retiring, effective immediately, the ...

Baxter International is selling its kidney care segment to Carlyle Group for $3.8 billion, most of which will be paid in cash. The Deerfield, Ill., medical-device maker on Tuesday said that it has ...

Concluding a two-year journey, Baxter International Inc.’s kidney care unit finally separated from the company and started a new life as Vantive, following the closing on Jan. 31 of its $3.8 billion ...

Deerfield: Baxter International Inc., has announced that José (Joe) E. Almeida, chair, president and chief executive officer ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive. This press ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...